National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 9/3/2021 release of VAERS data:

This is VAERS ID 1418742



Case Details

VAERS ID: 1418742 (history)  
Form: Version 2.0  
Age: 28.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-06-03
Onset:2021-06-03
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-06-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Headache, Nausea, SARS-CoV-2 test, Vision blurred, Vomiting
SMQs:, Acute pancreatitis (broad), Anticholinergic syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Glaucoma (broad), Lens disorders (broad), Retinal disorders (broad), Hypoglycaemia (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: FEXOFENADINE; RIGEVIDON [ETHINYLESTRADIOL;LEVONORGESTREL]
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Multiple allergies
Allergies:
Diagnostic Lab Data: Test Date: 20210604; Test Name: COVID-19 virus test; Test Result: Negative
CDC Split Type: GBPFIZER INC2021671637

Write-up: nausea; Vomiting; Headache; Blurred vision; This is a spontaneous report from a contactable consumer received from the Regulatory Agency. The regulatory authority report number is GB-MHRA-WEBCOVID-202106041931044710-8IILT, Safety Report Unique Identifier GB-MHRA-ADR 25423438. A 28-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 03Jun2021 as dose1, single for COVID-19 immunisation, at the age of 28-years-old. Medical history included multiple allergies. Patient had not had symptoms associated with COVID-19 and was not enrolled in clinical trial. Patient was not pregnant and was not currently breastfeeding. Concomitant medications included fexofenadine taken for multiple allergies from 09Aug2020 to an unspecified stop date; ethinylestradiol, levonorgestrel (RIGEVIDON) taken for an unspecified indication from 11Oct2019 to an unspecified stop date. The patient experienced nausea on 04Jun2021, vomiting, headache and blurred vision on 03Jun2021. The events were reported as serious as important medical events. It was reported that patient started with headache within half an hour, 5 hours later severe headache, blurred vision, vomiting. By morning after slight nausea and headache. The patient underwent lab tests and procedures which included COVID-19 virus test: negative on 04Jun2021. The patient was recovering from nausea and headache, had recovered from vomiting on 03Jun2021 and from blurred vision on 04Jun2021. No follow-up attempts are possible. Information about batch/lot number cannot be obtained.


New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1418742


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166